Page 2 - Serum Institute

We aim to be one of India's top CDMO, API players: Advent's Shweta Jalan

'Suven alone has multiple engines of growth across all segments and a strong pipeline of Phase 3 and late Phase 2 molecules'

Serum Institute, Byju's top Burgundy-Hurun unlisted companies list

The Pune-based vaccine producer's value has increased 20 per cent to Rs 2.2 trillion in the past one year

DCGI allows Serum Institute to export malaria vaccine to UK: Report

India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK, official sources said on Thursday. The Drugs Controller General of India (DCGI) has granted permission to send two lakh doses of the vaccine. The move comes after an application was submitted by Prakash Kumar Singh, director, Government and Regulatory Affairs, at Serum Institute of India (SII) to DCGI on September 27 seeking permission to export the vaccine against malaria, official sources told PTI. "SII has developed the vaccine against malaria under leadership of our CEO Dr Adar C Poonawalla. We have been relentlessly working to make available made-in-India and world-class vaccines against malaria to our country and world at large," an official source quoted Singh as having said in the application. Currently, only one vaccine against malaria is available globally and GSK is the ...

What is Khosta-2? A vaccine-restraint virus found in Russian bats

It is classified as a sarbecovirus, a member of the Coronavirus family. It attaches to the same protein, ACE2 that Coronavirus uses to penetrate into human cells

Serum Institute may give India its first adult tuberculosis vaccine

Will be critical to the success of India's drive to eliminate TB by 2025

India-made cervical cancer vaccine Ceravac to cost Rs 200-400 per dose

Serum India's product made in collaboration with state-run biotechnology department, expected to bring down prices

South Africa's Aspen, India's Serum Institute sign vaccines deal for Africa

South Africa's Aspen Pharmacare has signed a deal with the Serum Institute of India to manufacture and sell four Aspen-branded vaccines for Africa

At least 8 Indian companies working to develop monkeypox vaccine: Report

Among the companies that are working with ICMR are Serum Institute of India (SII), Reliance Life Sciences, Dr Reddy's Laboratories, and Biological E

Serum Institute explores new-age vaccine delivery systems for growth

The Pune-based company that manufactured the Covid-19 vaccine administered to most Indians is exploring more sophisticated delivery systems

What is keeping Adar Poonawalla busy these days?

Adar Poonawalla has taken Indian vaccines to the US and European markets. In an interview with Business Standard's Sohini Das, he tells about his plans for mass production of vaccines and more

We're geared to launch a new molecule every 1-2 years: Biocon Biologics MD

In an interview, Arun Chandravarkar explains why a company must continue investing in R&D despite the impact on short-term Ebitda

Mylab, firm that makes kits to detect Covid, starts pathology test facility

"We are now getting to 'wet' pathology tests like blood tests etc and we have set up a centre which will have minimal human intervention and maximum automation

Expert panel approves use of Serum Institute's Covovax for 7-11-year olds

India started vaccinating adolescents (aged 15-18) from January, and further expanded the drive to include children as young as 12 years from March

CCI approves Serum Institute Life Sciences-Biocon Biologics deal

The Competition Commission of India (CCI) has approved a proposed deal involving Serum Institute Life Sciences, Covidshield Technologies and Biocon Biologics. Once the deal is complete, Serum Institute Life Sciences Pvt Ltd will have about 15 per cent stake in Biocon Biologics Ltd, according to the notice filed with the regulator. Covidshield Technologies Pvt Ltd (CTPL), a wholly-owned subsidiary of Serum Institute of Life Sciences, will be merged into Biocon Biologics. In a tweet on Wednesday, the watchdog said it has cleared the "merger by absorption of Covidshield Technologies into Biocon Biologics in consideration for acquisition of approximately 15 per cent equity shareholding of Biocon Biologics by Serum Institute Life Sciences." CTPL was incorporated to undertake the business of marketing, selling and distributing vaccines, drugs and other pharmaceutical products. Biocon Biologics Ltd is a subsidiary of Biocon Ltd. It offers treatment for chronic and acute diseases such as

SII, Symbiosis to set up research centre for vaccine development

Serum Institute of India on Friday said it has signed an agreement with the Symbiosis International University earlier this month to set up a research centre for vaccines and biologicals. The R&D (Research & Development) centre will lead the development of new vaccines, technologies, products and innovations in immunisation practices that provide equitable access to life-saving interventions, especially across Low- and Middle-Income Countries (LMICs). The entity will work towards improving health equity against future pandemics and infectious diseases. It will also ensure cross-programme coordination and collaboration, as the facility will be an ecosystem that would also have R&D centres for stem cells, nanotechnology, medical image analysis, applied artificial intelligence and waste resource management, among others. "The research centre will be instrumental in advancing indigenous capabilities for end-to-end development of any futuristic technology and projects in the ...

Serum slashes Covishield price to Rs 225 a shot for pvt hospitals: Report

The decision, which the website attributes to Serum chief Adar Poonwala, comes a day ahead of the start of the programme to keep booster Covid-19 dose open for all adults

Two vaccines, Merck drug cleared for emergency use amid Omicron rise

150 mn doses of Corbevax, Covovax expected monthly from March

Adar Poonawalla picks up 20% stake in social media platform Wakau

Wakau offers a combination of mobile-first screen experience and short video content in entertainment and fashion domains

Billionaire Poonawalla family pledges $66 mn to Oxford for research campus

The pledge builds on the collaboration between Oxford University, AstraZeneca and SII, the world's largest maker of vaccines

Serum hopes to launch Novavax Covid vaccine for children in 6 months: CEO

The vaccine, called Covovax, has shown good results in trials in children aged three and older.